DeepTech Patient Capital Platform

🔴 Problem Identified

European venture capital has shifted from funding truly risky, innovative startups to focusing on safer, predictable investments resembling small-cap private equity. This "Safe Bet Syndrome" prioritizes revenue traction, market validation, and proven teams over groundbreaking technology and visionary founders, undermining venture capital’s role in generating outsized returns. Consequently, a funding gap has emerged for high-risk, transformative projects, stifling commercialization of breakthrough research. The current short-term, risk-averse investment model contrasts with past eras of technological leaps driven by patient, tolerant capital. To foster genuine innovation, Europe needs new, long-horizon investors willing to support early-stage, high-failure ventures, or it risks stagnating with only incremental progress.

💡 Proposed Solution

Create an online investment platform that pools capital from high-net-worth individuals, family offices, and institutional investors explicitly seeking patient, long-horizon (15-20 year) investments in early-stage, high-risk deeptech ventures. The platform will curate, vet, and support academic spinouts and breakthrough projects, offering structured investment vehicles with longer timelines, milestone-based funding, and robust commercialization support. Advisory services and a network of technic...

Register to read the full solution →